A. Contu

1.5k total citations
51 papers, 802 citations indexed

About

A. Contu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, A. Contu has authored 51 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Pathology and Forensic Medicine. Recurrent topics in A. Contu's work include Cancer Treatment and Pharmacology (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Lung Cancer Treatments and Mutations (8 papers). A. Contu is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Lung Cancer Treatments and Mutations (8 papers). A. Contu collaborates with scholars based in Italy, Austria and United Kingdom. A. Contu's co-authors include Lucia Del Mastro, Marco Venturini, Teodoro Chisesi, Paolo Bruzzi, Enrico Aitini, P. Pronzato, Giovanna Cavazzini, Gino Santini, Luigi Salvagno and P Coser and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

A. Contu

48 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Contu Italy 18 486 222 190 181 119 51 802
Janine Bell United Kingdom 10 423 0.9× 118 0.5× 113 0.6× 158 0.9× 122 1.0× 11 1.0k
Marianne Phillips Australia 14 461 0.9× 112 0.5× 157 0.8× 265 1.5× 127 1.1× 32 981
Sidnei Epelman Brazil 13 347 0.7× 160 0.7× 183 1.0× 101 0.6× 122 1.0× 43 918
Nicole Burchardi Germany 16 497 1.0× 59 0.3× 188 1.0× 164 0.9× 83 0.7× 39 938
Cynthia Harris United States 12 293 0.6× 222 1.0× 211 1.1× 53 0.3× 197 1.7× 17 759
Marco Fornili Italy 18 471 1.0× 94 0.4× 218 1.1× 160 0.9× 205 1.7× 48 1.1k
Katia Cannita Italy 18 596 1.2× 104 0.5× 217 1.1× 135 0.7× 130 1.1× 79 918
J M Birch United Kingdom 16 256 0.5× 71 0.3× 146 0.8× 95 0.5× 234 2.0× 19 980
M. R. Mahoney United States 13 721 1.5× 338 1.5× 198 1.0× 114 0.6× 103 0.9× 30 1.0k
C. Sawka Canada 8 357 0.7× 112 0.5× 62 0.3× 49 0.3× 130 1.1× 13 652

Countries citing papers authored by A. Contu

Since Specialization
Citations

This map shows the geographic impact of A. Contu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Contu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Contu more than expected).

Fields of papers citing papers by A. Contu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Contu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Contu. The network helps show where A. Contu may publish in the future.

Co-authorship network of co-authors of A. Contu

This figure shows the co-authorship network connecting the top 25 collaborators of A. Contu. A scholar is included among the top collaborators of A. Contu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Contu. A. Contu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palomba, Grazia, Maria Colombino, A. Contu, et al.. (2012). Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia. Journal of Translational Medicine. 10(1). 178–178. 28 indexed citations
2.
Palomba, Grazia, Angela Loi, Giovanna Piras, et al.. (2009). A role of BRCA1 and BRCA2germline mutations in breast cancer susceptibility within Sardinian population. BMC Cancer. 9(1). 245–245. 17 indexed citations
3.
Mastro, Lucia Del, Béatrice Dozin, Enrico Aitini, et al.. (2007). Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group. Annals of Oncology. 19(2). 299–307. 12 indexed citations
4.
Massidda, B., Francesco Atzori, A. Contu, et al.. (2007). Dose-Dense Primary Chemotherapy, as Part of Multidisciplinary Treatment, for Inoperable Stage III B Breast Cancer – Long-Term Results of a Phase II Trial. Oncology. 72(1-2). 17–26. 4 indexed citations
5.
Venturini, Marco, Lucia Del Mastro, Enrico Aitini, et al.. (2005). Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(23). 1724–1733. 107 indexed citations
6.
Palomba, Grazia, Marina Pisano, Antonio Cossu, et al.. (2005). Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital‐based screening. Cancer. 104(6). 1172–1179. 24 indexed citations
7.
Mastro, Lucia Del, Paolo Bruzzi, Guido Nicolò, et al.. (2005). HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. British Journal of Cancer. 93(1). 7–14. 28 indexed citations
8.
Passalacqua, Rodolfo, Caterina Caminiti, Stefania Salvagni, et al.. (2004). Effects of media information on cancer patients' opinions, feelings, decision‐making process and physician‐patient communication. Cancer. 100(5). 1077–1084. 52 indexed citations
9.
Venturini, Marco, Antonio Durando, Ornella Garrone, et al.. (2003). Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma. Cancer. 97(5). 1174–1180. 17 indexed citations
10.
Palmieri, Giuseppe, Grazia Palomba, Antonio Cossu, et al.. (2002). BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. Annals of Oncology. 13(12). 1899–1907. 19 indexed citations
11.
12.
Contu, A., et al.. (2001). Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Research and Treatment. 70(1). 1–10. 89 indexed citations
13.
Costanzo, Francesco Di, R Canaletti, N. Olmeo, et al.. (2000). Modulation of Fluorouracil by Methotrexate, Leucovorin, and Cisplatin (M-FLP) in the Treatment of Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 23(3). 314–318. 4 indexed citations
14.
Gebbia, Vittorio, Giovanna Mantovani, Biagio Agostara, et al.. (1995). Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: A multicenter phase II trial. Annals of Oncology. 6(10). 987–991. 18 indexed citations
15.
Sertoli, M.R., Gino Santini, Teodoro Chisesi, et al.. (1994). MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.. Journal of Clinical Oncology. 12(7). 1366–1374. 31 indexed citations
16.
17.
Rosso, R., G. Gardin, P. Pronzato, et al.. (1993). The Role of Lonidamine in the Treatment of Breast Cancer Patients. Annals of the New York Academy of Sciences. 698(1). 349–356. 2 indexed citations
18.
Salvagno, Luigi, A. Contu, N. Olmeo, et al.. (1992). A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma. Annals of Oncology. 3(10). 833–837. 34 indexed citations
19.
Chisesi, Teodoro, A. Contu, P Coser, et al.. (1991). Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: An interim report of a randomized study. European Journal of Cancer and Clinical Oncology. 27. S31–S33. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janine Bell Breakdown of academic impact, for papers by Marianne Phillips Breakdown of academic impact, for papers by Sidnei Epelman Breakdown of academic impact, for papers by Nicole Burchardi Breakdown of academic impact, for papers by Cynthia Harris Breakdown of academic impact, for papers by Marco Fornili Breakdown of academic impact, for papers by Katia Cannita Breakdown of academic impact, for papers by J M Birch Breakdown of academic impact, for papers by M. R. Mahoney Breakdown of academic impact, for papers by C. Sawka
Rankless by CCL
2026